Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Tuesday 22 October, 2019

Competition and Mkts

Merger Update: Roche / Spark

RNS Number : 5842Q
Competition and Markets Authority
22 October 2019



Start of CMA Merger Investigation: anticipated acquisition by Roche Holdings, Inc. of Spark Therapeutics, Inc.


The Competition and Markets Authority (CMA) is considering whether it is or may be the case that this transaction will result in the creation of a relevant merger situation under the merger provisions of the Enterprise Act 2002 and, if so, whether the creation of that situation may be expected to result, in a substantial lessening of competition within any market or markets in the United Kingdom for goods or services. 


The CMA announced the launch of its merger inquiry by notice to the Parties on 21 October 2019 and has a deadline of 16 December 2019 for its phase 1 decision.



This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

a d v e r t i s e m e n t